Carlos Garcia-Etienne

Omission of axillary surgery can be implemented without escalation of radiation. ⁦nice presentation by Matt Hager - BSO fellow @MayoCancerCare⁩ #asbrs2026

Endocrine therapy omission decreases survival in ER-low breast cancer. Great presentation @saskia_leonard @MayoCancerCare @MayoClinicSurg #SSO2026

September Issue: Impact of Unmet #SocialNeeds on Access to #BreastCancerScreening and Treatment: An Analysis of Barriers Faced by Patients in a #BreastCancer Navigation Program rdcu.be/eHBNY @cgarciaetienne @SyedAAhmad5

@ChandlerCortina @drsergioaguilar @adwilliams5 @ToanNguyenMD @AnnaChichuraMD @ferandang @EdiBonci @DrEmilySiegel @ErinMBayleyMD

@McMastersKelly @SyedAAhmad5 @FredDirbasMD @shaynalefrak @dr_laurad @abotty02 @LeeWilke @AndreaLMerrill @LucyMDeLaCruzMD @puneetsinghmd @belenmerck

ChatGPT likely to replace Google as a source of information for BC patients… Bayley et al: ChatGPT outperformed Google in providing high-quality answers and 88% of breast surgeons would recommend ChatGPT as a source over Google based on a blinded survey. rdcu.be/d9mBM

@McMastersKelly @SyedAAhmad5 @FredDirbasMD @shaynalefrak @dr_laurad @abotty02 @DrJudyBoughey @LeeWilke @AndreaLMerrill @LucyMDeLaCruzMD @puneetsinghmd @belenmerck @ChandlerCortina @drsergioaguilar @adwilliams5 @ToanNguyenMD @AnnaChichuraMD @ferandang @EdiBonci @DrEmilySiegel

@SocSurgOnc @AnnSurgOncol @ASBrS @ESSOnews @GBG_Forschung @EORTC_BCG @myBRESO @GretaOncoplast @EUBREAST @MSKCancerCenter

Surgical Perspectives on ASTRO PBI guideline rdcu.be/dVbbY 🧵 1/2: PBI safe and recommended alternative to WBRT: ≥40yo DCIS ≤2 cm or invasive BC pT1 pN0 G1-2 ER+ PBI conditionally recommended (caution when multiple factors present): G3 ER-negative pT2 ≤3 cm

From the September Issue of @annsurgoncol: Surgical Perspectives on the Updated ASTRO Guideline on Partial Breast Irradiation for #BreastCancer @shaynalefrak @FredDirbasMD rdcu.be/dVbbY @cgarciaetienne @SyedAAhmad5

September Issue: Surgical Perspectives on the Updated ASTRO Guideline on Partial Breast Irradiation for #BreastCancer @shaynalefrak @FredDirbasMD rdcu.be/dVbbY @cgarciaetienne @SyedAAhmad5

#AudioVisualAbstract : Establishment and Feasibility of an Immediate #LymphaticReconstruction Program in a #CommunityHealthSystem rdcu.be/dOk5E @cgarciaetienne @SyedAAhmad5

May Issue: A Prospective Study of #SentinelNodeBiopsy Omission in Women Age ≥ 65 Years with ER+ #BreastCancer @CatherineMDang rdcu.be/dIN1k @ChandlerCortina @belenmerck @SyedAAhmad5

#AudioVisualAbstract : Luminal A Versus B After Choosing Wisely: Does #LymphNodeSurgery Affect #OncologicOutcomes ? @kpmcguiremd rdcu.be/dIrw7 @puneetsinghmd @MikeCowher @SyedAAhmad5

Congrats ⁦@JenniferPlichta⁩ on a very important presentation about the importance of risk stratification for our patients with stage IV disease! ⁦@DukeSurgery⁩ ⁦@DukeCancer⁩ #SSO2024!

Nice presentation @cgarciaetienne on SLNB omission, the SOUND trial. In addition 2 Choosing Wisely supporting omission in pts >= 70yo, SOUND shows others who might be eligible for omission. ? is how will this impact multidisc decisions or trial enrollment, ie NRG DEBRA #SSO2024

Always great to meet Zoom friends IRL! @cgarciaetienne @clarongamd #SSO2024

Excited for the breast session "The evolution of sequence of treatment and axillary management" at #SSO2024 with this amazing group!!🤩🤩🤩 @abotty02 @dr_laurad @DrJudyBoughey @LeeWilke @cgarciaetienne